BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a report published on Tuesday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Trading Up 11.3 %

Shares of NASDAQ:BIOL opened at $0.01 on Tuesday. BIOLASE has a 12 month low of $0.02 and a 12 month high of $1.94. The company has a 50-day moving average price of $0.01 and a 200 day moving average price of $0.02. The company has a market cap of $297,322.30, a price-to-earnings ratio of 0.00 and a beta of 0.67.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.